Immunotherapy— A Powerful Tool in the Fight Against Cancer

Best Practices in Immunotherapy – June/July 2017 Vol 8
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Developer, Work Stride-Managing Cancer at Work, Johns Hopkins Healthcare Solutions

Dear Navigators,

On behalf of the JONS Editorial Board, it is my pleasure to present this special edition dedicated to the topic of immunotherapy. One of the many responsibilities of a navigator is to facilitate patient education—it is therefore imperative that we educate ourselves on new treatments, distill the information into lay terms, and use that information to effectively educate our patients.

I know that when patients initially receive a cancer diagnosis, among the barrage of thoughts and fears that simultaneously strike them is the assumption that they will receive chemotherapy. Whereas at one time chemotherapy was one of our only weapons in the fight against cancer, that is not true today. And while chemotherapies remain an effective tool, they are joined by other therapy options, including immunotherapies.

There are several types of immunotherapies, including monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines. All have the goal of empowering the body’s own immune system to fight cancer. Much of the information on immunotherapies is highly scientific in nature and presented in scholarly or academic venues, so it is important for navigators to find the correct tools to help our patients attain a thorough understanding of this therapeutic option in language that is accessible.

Immunotherapies are an important new weapon in our arsenal, and as navigators, we are obligated to learn all we can about them. I hope this issue increases your understanding of this exciting area of oncology treatment.

Sincerely,

Lillie Digital Signature

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+
University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship
Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles
Presenting the AONN+ 2021 Oncology Navigation Research Abstracts: Sharing Best Practices and Advancing the Navigation Profession
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
|
November 2021 Vol 12, No 11
Navigators from across the globe have conducted oncology navigation research and submitted their evidence-based findings to the Academy of Oncology Nurse & Patient Navigators 12th Annual Navigation & Survivorship Conference.
AONN+: Looking Forward with Optimism to 2022
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
|
December 2021 Vol 12, No 12
Here we are at the end of another rather unusual year. As the pandemic continues, we’ve had to adapt our oncology practices, our personal lives, and our professional organizations to function in the safest way possible.
The Countdown to the AONN+ Annual Conference!
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
|
October 2021 Vol 12, No 10
Last modified: November 5, 2020

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code